Join the club for FREE to access the whole archive and other member benefits.

Terray Therapeutics

Biotechnology company accelerating AI-driven drug discovery

Terray Therapeutics is a biotechnology company operating at the convergence of AI, biology, medicinal chemistry, automation, and nanotechnology to propel drug discovery into the information age. Terray’s proprietary integrated computational and experimental platforms generate massively scaled, powerfully agnostic chemical data that are purpose-built to power computational learning and reveal new interactions. This foundation is building an iterative, flexible chemistry engine that delivers more precise therapies to patients faster than ever before. 

The first step to powering an engine is to add the right fuel. We’re generating chemical data purpose-built for drug discovery in the information age.

A closed-loop system generates precise chemical datasets at unrivaled scale that work seamlessly with AI to systematically map biochemical interactions between small molecules and causes of disease. With unparalleled resolution, we’re finally able to meet the challenge of drug discovery with the power of both scale experimentation and modern computation, deriving insights that lead to new drugs for patients in need.

Visit website: https://terraytx.com/

 terray-therapeutics

Details last updated 16-Oct-2022

People at Terray Therapeutics

Jacob Berlin

CEO at Terray Therapeutics

Terray Therapeutics News

Terray raised $120 million to advance AI-driven drug discovery

Terray raised $120 million to advance AI-driven drug discovery

Longevity Technology - 21-Oct-2024

Their partnership with Calico focuses on age-related disease treatments

Calico-Terray Therapeutics collaborate to discover and advance therapeutics for diseases of aging

Calico-Terray Therapeutics collaborate to discover and advance therapeutics for diseases of aging

Calico - 12-Oct-2022

Terray’s novel microarray technology, combines wet lab and computer-driven drug development